Delivery Order SPE2DB22D2206-SPE2DB24FJS72
Award Date
8/9/24
Potential Completion Date
8/30/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ibrance 100 mg capsules, a prescription medication. The contract has a ceiling value of $8,122.48 and a performance period extending through May 16, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the provision of IBRANCE 100 MG TABLET 7S, a pharmaceutical product. The contract has a ceiling value of $7,796.30 and runs through July 12, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,118.08 contract is for the delivery of the medication Ibrance 125 mg Tablet 7s, with a performance period ending on May 19, 2025. This delivery order is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides global pharmaceutical support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IBRANCE 75 MG TABLET 7S, a pharmaceutical product, with a ceiling value of $48,743.76. The contract is a firm-fixed-price delivery order with a period of performance through July 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 125 MG TABLET 7S, a pharmaceutical product, with a ceiling value of $8,118.08 and a performance period ending on July 14, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of pharmaceutical products, including the prescription medication IBRANCE 125 MG TABLET 7S, to support U.S. government agencies and the Department of Defense. The contract has a ceiling value of $7,792.08 and a completion date of July 5, 2024. This delivery order is placed under Amerisourcebergen's...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 100 MG TABLET 7S, a pharmaceutical product, with a firm fixed price ceiling value of $8,122.48 and a period of performance ending on July 9, 2025. The contract was awarded on June 16, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This is a $8,122.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 100 MG TABLET 7S, a prescription medication, with a period of performance ending on July 8, 2025. The contract is not set aside and is awarded as part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ibrance 75 mg capsules, a brand-name pharmaceutical product. The contract has a firm fixed price of $8,123.96 and a period of performance ending on May 22, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IBRANCE 125 MG TABLET 7S. The contract has a firm fixed price of $7,792.08 and a completion date of October 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a...